Recombinant IL7RA (Lusvertikimab Biosimilar) antibody

Catalog No. ABIN7581529

The Human Monoclonal anti-IL7RA (Lusvertikimab Biosimilar) antibody has been validated for FACS, BLI, ELISA, Func and SPR. It is suitable to detect IL7RA (Lusvertikimab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL7RA (Lusvertikimab Biosimilar) antibody (ABIN7581529)

Target: IL7RA (Lusvertikimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL7RA (Lusvertikimab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-IL7RA (Lusvertikimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-IL-7Ra / CD127 Reference Antibody (lusvertikimab)

Characteristics: Anti-IL-7Ra / CD127 Reference Antibody (lusvertikimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for IL7RA (Lusvertikimab Biosimilar)

Target: IL7RA (Lusvertikimab Biosimilar)

Alternative Name: IL-7Ra (Lusvertikimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P16871